Pharma Pulse 2/19/25: The Impact of Telehealth Reimbursement Policies, Cuts to Indirect Research Costs To Impact T1D & more

Impact of Telehealth Reimbursement Policies on Federally Qualified Health Centers

A qualitative study examines how Medicaid telehealth reimbursement policies affect staffing and patient-centered care.

Cuts to Indirect Research Costs To Impact Type 1 Diabetes

Aaron J. Kowalski, PhD, CEO of Breakthrough T1D, spoke with Managed Healthcare Executive, about the possible impacts of the NIH’s cuts to indirect research funding.

New York State Bans DeepSeek From Government Devices

New York state banned the use of DeepSeek on government devices, citing concerns over data privacy and censorship in the popular generative artificial intelligence app from China.

DeepSeek, owned by Chinese hedge fund High-Flyer, shot to fame in January, with its low-cost AI models rivaling American ones using less-advanced Nvidia chips.

Bayer^® Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to “See Their Risks”

In the United States alone, 104 million people are at risk of cardiovascular disease, and in a study of those that experienced a heart attack at age 50 or younger, half were not previously seen as high risk. This February, Bayer^® Aspirin is marking Heart Health Month with a new initiative to raise awareness and education about cardiovascular risk factors — especially among those who may dismiss the connection between age and heart health — and empower people to take proactive steps toward protecting their heart health by speaking with their healthcare provider about their risk factors.

Miranda Schmalfuhs on LinkedIn

You saw my 4-part video interview with Sooth® Founder and CEO Ian Baer but there was SO MUCH MORE that didn't make the edit! Check out the latest episode of the Pharmaceutical Executive podcast to hear the rest — you'll be glad you did!

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs